Reducing HIV among adolescent girls in sub-Saharan Africa

Janssen (a J&J company)
Life science/Healthcare


HIV/AIDS is the leading cause of death among adolescent girls and young women age 15-24 in sub-Saharan Africa, a region that also has high rates of TB. Our client is deeply engaged in reducing their risk. The project should develop an out-of-the-box approach to remedy the situation.

For this project, which could have a major impact on HIV/AIDS, we are looking for individuals to compete with brief, written contributions. You would eventually form a team composed of a variety of professional backgrounds and perspectives, ranging from private to public sector, young to more experienced public health, policy, and other experts, consultants, medical personnel, industry professionals, technologists, communicators, academics, government, and IGO/NGO-personnel with sub-Saharan Africa experience, insight, or access, particularly in the adolescent girl segment. A minimum of one of the team members is expected to have strong project/consulting management experience.

NB: The max. compensation per team member is $5000 up to a max of $20,000 if the challenge is awarded to a 4 person team. Whilst they/you are free to compete to join and contribute to the team solution, no government officials or practicing physicians may receive payment as part of this project.

How to get involved
To become involved, one must follow two simple steps. The first is to register and identify your experience as an expert on the Yegii platform here. The second step is to submit an initial online response here to the easier question: What is current best practice in HIV/Aids prevention among adolescent girls?

About Yegii
Making consulting scalable, data driven, and virtual by clustering brain capacity and innovation analytics, Yegii is the definitive resource for industries re-shaped by emerging technology, policy, user dynamics or business models. For more info on our process for solving challenges and engaging experts, consult Yegii's website.

About Janssen (the client)
Janssen Global Services LLC consists of more than 30,000 people working hard to prevent, treat, cure and stop some of the most devastating and complex diseases of our time. Janssen is the pharmaceutical arm of the multinational life science giant Johnson & Johnson, which operates in 60 countries, has 126,500 employees and $74.3 Bn in revenue (2014).

Deadline: Thursday, December 03 , 2015
What is current best practice in HIV/Aids prevention among adolescent girls? Briefly, using 2-3 paragraphs, sketch some observations.

Deadline: Saturday, December 05, 2015

Deadline: Monday, February 01, 2016